123 related articles for article (PubMed ID: 2998813)
21. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.
Görnemann T; von Wenckstern H; Kleuser B; Villalón CM; Centurión D; Jähnichen S; Pertz HH
Br J Pharmacol; 2007 May; 151(2):186-94. PubMed ID: 17375080
[TBL] [Abstract][Full Text] [Related]
22. Alpha 2C-adrenoceptors mediate contractile responses to noradrenaline in the human saphenous vein.
Gavin KT; Colgan MP; Moore D; Shanik G; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):406-11. PubMed ID: 9089673
[TBL] [Abstract][Full Text] [Related]
23. Pacing-induced heart failure in the dog: evaluation of peripheral vascular alpha-adrenoceptor subtypes.
Forster C; Armstrong PW
J Cardiovasc Pharmacol; 1990 Nov; 16(5):708-18. PubMed ID: 1703591
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological analysis of neurogenic, sympathetic responses mediated through alpha-1-, alpha-2-adrenergic and purinergic receptors in the dog saphenous vein.
Hiraoka Y; Taniguchi T; Oshita M; Muramatsu I
Pharmacology; 2000 May; 60(4):188-94. PubMed ID: 10828743
[TBL] [Abstract][Full Text] [Related]
25. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin.
Eskinder H; Hillard CJ; Olinger GN; Christensen CW; Baker JE; Warltier DC; Gross GJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):941-8. PubMed ID: 2905005
[TBL] [Abstract][Full Text] [Related]
26. The effects of cooling on human saphenous vein reactivity to adrenergic agonists.
Harker CT; Ousley PJ; Harris EJ; Edwards JM; Taylor LM; Porter JM
J Vasc Surg; 1990 Jul; 12(1):45-9. PubMed ID: 2165189
[TBL] [Abstract][Full Text] [Related]
27. Contributions of alpha 1-adrenoceptors, alpha 2-adrenoceptors and P2x-purinoceptors to neurotransmission in several rabbit isolated blood vessels: role of neuronal uptake and autofeedback.
MacDonald A; Daly CJ; Bulloch JM; McGrath JC
Br J Pharmacol; 1992 Feb; 105(2):347-54. PubMed ID: 1313725
[TBL] [Abstract][Full Text] [Related]
28. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):299-303. PubMed ID: 6096723
[TBL] [Abstract][Full Text] [Related]
29. An examination of the pre- and postsynaptic alpha-adrenoceptors involved in neuroeffector transmission in rabbit aorta and portal vein.
Docherty JR; Starke K
Br J Pharmacol; 1982 Jun; 76(2):327-35. PubMed ID: 6284293
[TBL] [Abstract][Full Text] [Related]
30. Evidence that the population of postjunctional-adrenoceptors mediating contraction of smooth muscle in the rabbit isolated ear vein is predominantly alpha 2.
Daly CJ; McGrath JC; Wilson VG
Br J Pharmacol; 1988 Aug; 94(4):1085-90. PubMed ID: 2905182
[TBL] [Abstract][Full Text] [Related]
31. An examination of the postjunctional alpha-adrenoceptor subtypes for (-)-noradrenaline in several isolated blood vessels from the rabbit.
Daly CJ; McGrath JC; Wilson VG
Br J Pharmacol; 1988 Oct; 95(2):473-84. PubMed ID: 2852522
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the actions of chloroethylclonidine in rat aorta.
O'Rourke M; Kearns S; Docherty JR
Br J Pharmacol; 1995 Aug; 115(8):1399-406. PubMed ID: 8564198
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic alpha-adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?
Baker DJ; Drew GM; Hilditch A
Br J Pharmacol; 1984 Mar; 81(3):457-64. PubMed ID: 6320940
[TBL] [Abstract][Full Text] [Related]
34. Characterization of alpha-adrenoceptors mediating sympathetic vasoconstriction in rat autoperfused hindlimb: effects of SK&F 104078.
Medgett IC; Ruffolo RR
Eur J Pharmacol; 1987 Dec; 144(3):393-7. PubMed ID: 2894316
[TBL] [Abstract][Full Text] [Related]
35. Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.
MacLennan SJ; Luong LA; Jasper JR; To ZP; Eglen RM
Br J Pharmacol; 1997 Aug; 121(8):1721-9. PubMed ID: 9283709
[TBL] [Abstract][Full Text] [Related]
36. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
37. Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.
Fukui D; Yang XP; Chiba S
Br J Pharmacol; 2005 Mar; 144(6):737-42. PubMed ID: 15685216
[TBL] [Abstract][Full Text] [Related]
38. Neuronally released norepinephrine does not preferentially activate postjunctional alpha 1-adrenoceptors in human blood vessels in vitro.
Stevens MJ; Moulds RF
Circ Res; 1985 Sep; 57(3):399-405. PubMed ID: 2863008
[TBL] [Abstract][Full Text] [Related]
39. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein.
Flavahan NA; Rimele TJ; Cooke JP; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Sep; 230(3):699-705. PubMed ID: 6088763
[TBL] [Abstract][Full Text] [Related]
40. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
Daly RN; Sulpizio AC; Levitt B; DeMarinis RM; Regan JW; Ruffolo RR; Hieble JP
J Pharmacol Exp Ther; 1988 Oct; 247(1):122-8. PubMed ID: 2902209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
